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Abstract 
Background: Adherence to antihypertensive medications is a key component to control blood pressure levels. 
Poor adherence to these medications leads to the development of hypertensive complications and increase risk of 
cardiovascular events which in turn reduces the ultimate clinical outcome. The purpose of this study was to assess 
antihypertensive medication adherence and associated factors among adult hypertensive patients. A hospital-based 
cross-sectional study among adult hypertensive patients was conducted at hypertensive follow-up clinic of Jimma 
University Specialized Hospital from March 4, 2015 to April 3, 2015. A simple random sampling technique was used to 
select the study participants from the study population. The study patients were interviewed and their medical charts 
were reviewed using a pretested structured questionnaire. Adherence was assessed using Morisky Medication Adher-
ence Scale-8 (MMAS-8) and MMAS-8 score less than 6 was considered as non-adherent and MMAS-8 score was ≥ 6 
was declared as adherence. Factors associated with adherence were identified using binary and multivariate logistic 
regression analysis. Crude odds ratio, adjusted odds ratio (AOR) and 95% confidence interval of the odds ratio were 
calculated using SPSS version 21. Variables with p-value less than 0.05 were assumed as statistically significant factors.
Results: Among 280 hypertensive patients, 61.8% of the study participants were found to be adherent. More than 
half (53.2%) of the participants were males and the mean age of the participants was 55.0 ± 12.7 years. Co-morbidity 
(AOR = 0.083, 95% CI = 0.033–0.207, p < 0.001), alcohol intake (AOR = 0.011, 95% CI = 0.002–0.079, p < 0.001), get-
ting medications freely (AOR = 0.020, 95% CI = 0.003–0.117, p < 0.001), and combination of antihypertensive medi-
cations (AOR = 0.32, 95% CI = 0.144–0.712, p < 0.005) were inversely associated with antihypertensive medication 
adherence.
Conclusion: The adherence level to the prescribed antihypertensive medications was found to be sub-optimal 
according to the MMAS-8, and influenced by co morbidity, alcohol intake, self-purchasing of the medications and 
combination of antihypertensive medications.
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Background
Hypertension is the most significant risk factor for car-
diovascular disease and its prevalence is still increasing 
globally [1–3]. Worldwide, more than half of the hyper-
tensive patients have systolic blood pressure (SBP) ≥ 140 
and/or diastolic blood pressure (DBP) ≥  90  mmHg [4]. 
The rate of blood pressure (BP) control varies from coun-
try to country in which the level of controlled BP among 
treated cases were 65, 50, 40, 32.8 and 30% in Bahrain, 
USA, England, Zimbabwe, and Germany respectively 
[5–9]. In developing countries, the high prevalence of 
hypertension compounded with poor hypertension con-
trol remain a significant public health problem [10–12].
Taking antihypertensive medications properly is a 
central point in the management of hypertension. Effec-
tive antihypertensive treatment should be maintained 
indefinitely to reduce the relative risk of stroke and 
other cardiovascular disease events [13]. However, due 
to the asymptomatic nature of the disease and indefi-
nite treatment duration, medication adherence remains 
a significant challenge among these patients. Therefore, 
adherence to antihypertensive medication therapy is the 
main predictor of treatment success and an effective step 
in controlling BP and preventing complications [14].
The World Health Organization (WHO) identifies poor 
adherence as the most significant cause of uncontrolled 
BP and estimates that 50–70% of people do not take their 
antihypertensive medication as prescribed [15]. In Ethio-
pia, studies done in Adama and Gonder showed that the 
level of adherence to antihypertensive treatment was 
59.9 and 64.6% respectively. The level of adherence in the 
studies meant that percentage of patients having good 
adherence divided by the total studied population [16, 
17].
Poor adherence is responsible for unnecessary over-
prescription of drugs, substantial worsening of diseases, 
increases in avoidable hospital admission rates and 
longer hospital stays which all leading to a significant 
medical burden such as reduced optimal clinical benefit 
and increased risk of cardiovascular events [14, 18–20]. 
Additionally, findings in clinical practice have raised 
issues about under treatment and non-adherence to anti-
hypertensive treatment hampering the effectiveness of 
the medications [21].
There are various factors that affect a hypertensive 
patient’s behavior regarding adherence to antihyperten-
sive treatments. Knowledge about hypertension and its 
treatment, socio-demographics, beliefs about treatment, 
patient-provider relationship and the support received 
from healthcare services are the factors that affect hyper-
tensive patient’s adherence [22]. Identifying factors that 
affect medication adherence is the first step towards 
improving adherence [23]. Therefore; the aim of this 
study was to assess antihypertensive medication adher-
ence and associated factors among adult hypertensive 
patients attending Jimma University Specialized Hospital 
(JUSH).
Methods
A hospital-based cross-sectional study among hyperten-
sive adult patients was conducted at the hypertension 
clinic of JUSH from March 4, 2015 to April 3, 2015. JUSH 
is a teaching and referral hospital with 523 beds serving 
for approximately 20,000 admissions and 140,000 outpa-
tient visits a year with a catchment population of about 
15 million people. Hypertensive patients receive services 
and medications every month at the clinic. Considering 
1.96 for the standard normal variable with 5% level of sig-
nificance (α-value), 95% confidence interval, 5% margin 
of error and 10% contingency, the sample size was calcu-
lated to be 311 from the study population.
The study was approved by the Institutional Review 
Board of Collage of Public Health and Medical Sciences, 
Jimma University. An informed written consent was 
obtained from all patients. Then face-to-face interview 
with a pretested structured questionnaire was conducted 
to collect the socio-demographics, clinical characteris-
tics and adherence status of patients to antihypertensive 
medication(s). The face to face interview was employed 
using six trained clinical nurses. The data were collected 
by a trained six clinical nurses who used to work at the 
hypertensive clinic but who did not work at the clinic 
during the study period. Data on co-morbidities, antihy-
pertensive medication(s) and a 1 year BP measurements 
were extracted from medical records of patients using a 
pretested data abstraction format.
All hypertensive patients aged 18  years and above, 
who had a regular follow-up for at least 12 months at the 
clinic, patients who used an antihypertensive medication 
for hypertension and whose medical records contained 
complete data and who were willing to participate were 
included in the study. Seriously ill patients who were not 
able to finish the interview, patients on DASH therapy 
alone (i.e. with no drug therapy) and patients with incom-
plete medical records were excluded from the study.
To maintain validity of the data collection tool, a struc-
tured questionnaire was developed and translated into 
local languages (Amharic and Afan Oromo) and back 
translated to English. An eight item Morisky’s Medica-
tion Adherence Scale (MMAS-8) was employed to assess 
the study participant’s medication adherence. A scoring 
scheme of “Yes” = 0 and “No” = 1 for the first seven items 
except item number five in which the values are of “Yes” 
and “No” were reversed and for the last item a five-point 
Likert response was used with options “never”, “once in 
a while”, “sometimes”, “usually”, and “always” (Additional 
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file 1) [24]. The primary outcome of the study was antihy-
pertensive medication adherence status.
Operational definitions
Hypertension was defined as sustained high BP 
(SBP  ≥  140 or DBP  ≥  90  mmHg) or reported regular 
use of antihypertensive medication(s) [9]. Uncontrolled 
BP was defined as SBP of  ≥  140  mmHg and/or DBP 
of ≥  90  mmHg [25]. Controlled BP was defined as SBP 
of < 140 mmHg and/or DBP of < 90 mmHg [25]. Patients 
were considered as non-adherent to their medication(s) 
when MMAS-8 score was less than 6 and adherence was 
considered when the patient’s MMAS-8 score was ≥  6 
[26, 27]. Rate of adherence was defined as the number of 
adherent participants divided by the total number of par-
ticipants. Rate of BP control was also defined as the num-
ber of participants with controlled BP divided by the total 
number of participants.
Statistical analysis
Data were analyzed using Statistical Package for Social 
Sciences  (SPSS®statistics) program version 21 (SPSS; 
Chicago, IL, USA). Binary logistic regression analysis 
was employed to identify determinants of medication 
adherence. Variables with p-values < 0.25 on a univariate 
logistic regression model were entered into a multivariate 
logistic regression and variables with p value < 0.05 were 
considered as statistically significant.
Results
In this study, a total of 311 participants were fulfilled inclu-
sion criteria and invited to interview and of this, 286 had 
completed interview. Of the 286 participants who com-
pleted interview, 6 participants were on a DASH ther-
apy and were excluded from analysis (Fig. 1). The overall 
response rate was 92%. As shown in Table  1, more than 
half (53.2%) of the participants were males. The mean 
age of the participants was 55.0 ± 12.7 years, with mini-
mum 26 and maximum of 94 years old. About one-fourth 
(n = 25.4%) of the patients were elders (65 years and older). 
Above three-quarter (78.6%) of the participants were mar-
ried. Regarding duration of hypertension, 162 (57.9%) 
patients have a duration of less than 5 years (Table 1).
On the other hand, more than half (n = 164, 58.6%) of 
the participants had at least one written evidence of co 
morbidity (Fig.  2). 73 (26.1%) participants had diabetes 
compared to 65 (23.2%) patients who had peripheral neu-
ropathy (Table 1).
As depicted in Table 3, 173 (61.8%) of the participants 
were adherent to their antihypertensive medication 
Total patients who fulfill the inclusion criteria and 
invited to complete the study=311 




Total patients analyzed=280 
Total patients who 
were solely on 
DASH therapy=6 
Fig. 1 Hypertension patient selection flow chart at Jimma University Specialized Hospital from March 4, 2015 to April 3, 2015. DASH dietary 
approach to stop hypertension
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compared to 107 (38.2%) patients who were non adherent 
(Table 2).
Antihypertensive medications and blood pressure control
The average number of antihypertensive medications 
prescribed per patient was 2.9 ± 0.7. Among the 280 par-
ticipants, 173 (61.8%) were prescribed with more than 
one antihypertensive medication. Above half (53.2%) of 
the study patients were on two medications compared 
to 84 (30%) patients who were on mono-therapy and 
46 (16.4%) patients who were on triple therapy (Fig.  3). 
Among the participants on mono-therapy, 53 (63.1%) of 
them had controlled blood pressure.
The mean of SBP means of the participants was 
132.5  ±  20.3  mmHg, range 90–190  mmHg and the 
mean of DBP means was 81.7  ±  12.0  mmHg, range 
50–90 mmHg.
Antihypertensive medication adherence and associated 
factors
As shown in Table 3, the presence of co-morbidity, reg-
ular alcohol intake, self-purchasing of the medications 
and combinations of antihypertensive medications were 
significantly but inversely associated antihypertensive 
medication adherence. Accordingly, patients with comor-
bidities (AOR  =  0.083, CI  =  0.033–0.207, p  <  0.001) 
were 12 times more likely to be non-adherent com-
pared to patients without comorbidities. As well, those 
taking alcohol (AOR  =  0.011, 95% CI  =  0.002–0.079, 
p < 0.001) were 90 times more likely to be non-adherent 
compared to patient who were not take alcohol. In addi-
tion, those paying for their medication (AOR  =  0.020, 
CI = 0.003–0.117, p < 0.001) were 50 times more likely 
to be non-adherent, and those taking more than one drug 
(AOR = 0.32, 95% CI = 0.144–0.712, p < 0.005) were 3 
times more likely to be non-adherent (Table 3).
Discussions
Adherence to antihypertensive medications as measured 
using MMAS-8 in JUSH was 61.8% when defined by the 
MMAS-8 ≥ 6 cut off. Evidence of comorbidity, daily alco-
hol intake, purchasing medications with own expense 
and patients with two and more than two antihyperten-
sive medications were the factors showing inverse asso-
ciation with medication adherence.
More than half, 61.8% of the study subjects in JUSH 
were found to be adherent to their antihypertensive med-
ication treatment. This adherence level was lower than 
the findings of other studies reported in Egypt (77%), in 
Table 1 Frequency distribution of socio demographic 
and clinical characteristics of hypertensive patients 
at Jimma University Specialized Hospital from March 4, 
2015 to April 3, 2015 (N = 280)
Characteristics N (%)
Age in years, mean ± SD 55.05 ± 12.66
 Below 35 10 (3.6)
 35–44 47 (16.8)
 45–54 76 (27.1)
 55–64 76 (27.1)
 65 and above 71 (25.4)
Gender
 Male 149 (53.2)
 Female 131 (46.8)
Marital status
 Single/widowed 19 (6.8)
 Married 220 (78.6)
 Divorced 41 (14.6)
Educational level
 No formal education 108 (38.6)
 Primary education (grade 1–8) 66 (23.6)
 Secondary education (grade 9–12) 45 (16.1)
 Tertiary education (diploma and/or above) 61 (21.7)
Religion
 Islam 130 (46.4)
 Orthodox Christian 125 (44.6)
 Protestant 25 (8.9)
Occupation
 Civil servant 78 (27.9)
 Merchant 35 (12.5)
 Farmer 46 (16.4)
 Unemployed 121 (43.2)
Duration of hypertension in years, mean ± SD 5.1 ± 4.1 years
 < 5 162 (57.9)
 ≥ 5 118 (42.1)
 Type of comorbidity
  Diabetes mellitus 73 (26.1%)
  Peripheral neuropathy 65 (23.2%)
  Dyspepsia 32 (11.4%)
  Hypertrophic heart disease 14 (5.0%)
  Heart failure 7 (2.5%)
  Chronic kidney disease 6 (2.1%)
  Urinary tract infection 6 (2.1)
  Human immune virus 4 (1.4)
  Ischemic heart disease 4 (1.4)
  Asthma 3 (1.1)
  Sexual dysfunction 3 (1.1)
  Others 9 (3.1)
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Pakistan (77%) and in Scotland (91%) [26–28]. Variations 
in the studied populations, assessment tool and cut off 
points of the studies might contribute to the adherence 
variation between the studies. For instance, the study 
from Pakistan was used MMAS-4 as assessment tool to 
measure adherence [27]. Moreover, better health care and 
access of health facilities in the developing countries like 
Egypt and Scotland may also enhance patient’s adherence 
as compared to our study [26, 28]. On the other hand, the 
adherence level reported in this study was higher than 
the findings from Malaysia (44.2%) and Gambia (27%) 
[25, 26]. This difference might be explained as 32.2% of 
the participants in this study received free medical care 
and medications, whereas, in the aforementioned com-
parative studies, patients had to pay for their treatment. 
Our studies level of adherence was relatively quiet con-
gruent to local studies conducted in Gonder, Northwest 
Ethiopia (64.6%) and Adama, Ethiopia (59.5%) [16, 17]. 
This might be owing to similarity in the study setting and 
economic status of the study participants.
In this study, co-morbidity was significantly associ-
ated with anti-hypertensive medication adherence. Study 
participants with one or more co-morbidities were less 
likely to adhere to their antihypertensive medications 
than their counter parts. There were also similar findings 
from Ethiopia and Saudi Arabia that showed comorbid-
ity as factor tackling adherence [7, 16]. The plausible rea-
son could be due to a complicated treatment regimen as a 
result of the increased number of medications prescribed 
Fig. 2 Prevalence of co morbidity among hypertensive patients at 
Jimma University Specialized Hospital from March 4, 2015 to April 3, 
2015
Table 2 A summary of responses to the eight-item Moriskiy’s Medication Adherence Scale among adult hypertensive 
patients at Jimma University Specialized Hospital March 4, 2015 to April 3, 2015. This table been removed 
because the authors have not obtained a licence to use the Morisky Medication Adherence Scale-8 (MMAS-8). The results 
presented in this table are available by contacting the authors
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for both the hypertension and the co-morbidities might 
result to polypharmacy and pill burden which ultimately 
hinder adherence.
Another important factor that influences patient com-
pliance is the number of medications prescribed. Num-
ber of prescribed antihypertensive medications was also 
significantly associated with adherence. Participants who 
were taking two and/or more medications were less likely 
to adhere to their medications compared to participants 
who were on mono-therapy. There are similar findings 
from Greek [29] and Malaysia [26]. According to a sys-
tematic review of randomized controlled trials, reduction 
of the number of daily doses of antihypertensive medi-
cation, may improve adherence [30]. Regimens with one 
tablet per day are quite simple and as a consequence, 
patients find them easy to follow without forgetting their 
daily dose [31]. Hence combination and preparation of 
the two antihypertensive medication as one tablet might 
improve patient’s adherence. This is particularly true for 
the elderly hypertensive patient who usually suffer from 
several comorbidities. It must be noted that, it is difficult 
to adequately control blood pressure of elderly hyperten-
sive patients and patients with comorbidity with a simple 
antihypertensive drug [32]. Thus, usually this problem 
can be solved with the use of a tablet, which combines 
more than one drug, which is very difficult to apply in 
our setting.
In addition to this, daily alcohol intake and purchas-
ing medications with own expense were significantly 
associated with antihypertensive medication adherence. 
Daily alcohol intake significantly hinders adherence sta-
tus of the participants. Nevertheless, this was not in line 
with a study done in Hyderabad [33]. This might be due 
to discrepancies in the assessment tool used. This study 
used MMAS-8 while the study from India used MMAS-
4. Moreover, participants who purchased medications 
by themselves were less likely to adhere to their medica-
tions than participants who get their mediations freely. 
This is similar with a study done in northwest Ethiopia 
which showed higher odds of adherence to antihyper-
tensive medications in respondents who had got the 
medication/s free of charge or with low cost as compared 
to those who had got the medication/s with high cost 
[34]. This might be attributable to the economic con-
straint of the former participants. Since Ethiopia is one of 
Fig. 3 Number of antihypertensive medications among hypertensive 
patients at Jimma University Specialized Hospital March 4, 2015 to 
April 3, 2015
Table 3 Results of logistic regression analysis for factors associated with medication adherence among adult 
hypertensive patients on treatment at Jimma University Specialized Hospital from March 4, 2015 to April 3, 2015
AOR adjusted odds ratio, CI confidence interval, COR crude odds ratio, DM diabetes mellitus, HHD hypertensive heart disease, (1) reference category, HTN hypertension
* Statistically significant at p < 0.05
Variables Medication adherence COR (95% CI), p-value AOR (95% CI), p-value
Non adherent (%) Adherent (%)
Number of anti-HTN medications
 1 medication 24 (22.4) 83 (77.6) (1) (1)
 ≥ 2 medications 84 (48.6) 89 (51.4) 0.306 (0.178–0.527), p < 0.001* 0.32 (0.144–0.712*), p < 0.005*
Alcohol intake
 Yes 46 (95.8) 2 (4.2) 0.016 (0.004–0.067), p < 0.001* 0.011 (0.002–0.079), p < 0.001*
 No (1) 62 (26.7) 170 (73.3) (1) (1)
Presence of co-morbidities
 Yes 92 (56.1) 72 (43.9) 0.125 (0.068–0.231), p < 0.001* 0.083 (0.033–0.207), p < 0.001*
 No (1) 16 (13.8) 100 (86.1) (1) (1)
Obtaining of anti-HTN medications
 Paid 106 (56.1) 83 (43.9) 0.018 (0.004–0.074), p < 0.001* 0.020 (0.003–0.117), p < 0.001*
 Free (1) 2 (2.2) 89 (97.8) (1)
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the developing countries low daily income in association 
with low awareness might hamper patient’s adherence. 
Thus, patient’s awareness creation and availing afford-
able medication might enhance adherence and ultimately 
improve patient’s outcome.
The study has certain limitation. A cross-sectional 
study was conducted which did not allow follow-up of 
the participants. Besides this, the study was conducted 
at a single center with a modest number of individuals, 
which might limit generalization of the findings to wider 
contexts.
Conclusion
The adherence level to the prescribed antihypertensive 
medications was found to be sub-optimal. Moreover, 
daily alcohol intake, co-morbidity, number of antihyper-
tensive medications and availability of medications with-
out fee are the factors affecting adherence. These findings 
open multiple avenues that health care providers should 
pay due attention to the importance of adherence and the 
influencing factors of adherence.
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